Damien King
Directeur Général chez Avari Medical
Profil
Damien King is the founder of Merz Pharma Canada Ltd.
which was founded in 2009.
He held the title of Sales Director from 2009 to 2019.
Currently, he is the President & Chief Executive Officer at Avari Medical since 2019.
He previously worked as an Independent Director at Aequus Pharmaceuticals, Inc. Mr. King has an MBA from Cornell University and an undergraduate degree from Simon Fraser University.
Postes actifs de Damien King
| Sociétés | Poste | Début |
|---|---|---|
| Avari Medical | Directeur Général | 01/04/2019 |
Anciens postes connus de Damien King
| Sociétés | Poste | Fin |
|---|---|---|
Merz Pharma Canada Ltd.
 Merz Pharma Canada Ltd. Pharmaceuticals: MajorHealth Technology Merz Pharma Canada Ltd. engages in the research and market of drugs for treatment of neurological and psychiatric diseases. Its products include Belotero, Radiesse, Ultherapy, Xeomin, Neocutis, and Mederma. The company was founded in 2009 and is headquartered in Burlington, Canada. | Fondateur | 01/04/2019 |
| AEQUUS PHARMACEUTICALS INC. | Directeur/Membre du Conseil | - |
Formation de Damien King
| Cornell University | Masters Business Admin |
| Simon Fraser University | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AEQUUS PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Merz Pharma Canada Ltd.
Merz Pharma Canada Ltd. Pharmaceuticals: MajorHealth Technology Merz Pharma Canada Ltd. engages in the research and market of drugs for treatment of neurological and psychiatric diseases. Its products include Belotero, Radiesse, Ultherapy, Xeomin, Neocutis, and Mederma. The company was founded in 2009 and is headquartered in Burlington, Canada. | Health Technology |
| Avari Medical |
